27893178|t|Comprehensive genetic characterization of rosette-forming glioneuronal tumors: independent component analysis by tissue microdissection
27893178|a|A rosette-forming glioneuronal tumor (RGNT) is a rare mixed neuronal-glial tumor characterized by biphasic architecture of glial and neurocytic components. The number of reports of genetic analyses of RGNTs is few. Additionally, the genetic background of the unique biphasic pathological characteristics of such mixed neuronal-glial tumors remains unclear. To clarify the genetic background of RGNTs, we performed separate comprehensive genetic analyses of glial and neurocytic components of five RGNTs, by tissue microdissection. Two missense mutations in FGFR1 in both components of two cases, and one mutation in PIK3CA in both components of one case, were detected. In the latter case with PIK3CA mutation, the additional FGFR1 mutation was detected only in the glial component. Moreover, the loss of chromosome 13q in only the neurocytic component was observed in one other case. Their results suggested that RGNTs, which are tumors harboring two divergent differentiations that arose from a single clone, have a diverse genetic background. Although previous studies have suggested that RGNTs and pilocytic astrocytomas (PAs) represent the same tumor entity, their results confirm that the genetic background of RGNTs is not identical to that of PA.
27893178	14	21	genetic	T017	UMLS:C0017337
27893178	42	77	rosette-forming glioneuronal tumors	T038	UMLS:C2363902
27893178	91	100	component	T017	UMLS:C0243092
27893178	113	119	tissue	T017	UMLS:C0475358
27893178	120	135	microdissection	T058	UMLS:C0598304
27893178	138	172	rosette-forming glioneuronal tumor	T038	UMLS:C2363902
27893178	174	178	RGNT	T038	UMLS:C2363902
27893178	190	216	mixed neuronal-glial tumor	T038	UMLS:C0474844
27893178	234	255	biphasic architecture	T033	UMLS:C1332555
27893178	259	264	glial	T017	UMLS:C0027836
27893178	269	279	neurocytic	T017	UMLS:C0027882
27893178	280	290	components	T017	UMLS:C0243092
27893178	317	333	genetic analyses	T058	UMLS:C0796344
27893178	337	342	RGNTs	T038	UMLS:C2363902
27893178	402	439	biphasic pathological characteristics	T038	UMLS:C0030660
27893178	448	475	mixed neuronal-glial tumors	T038	UMLS:C0474844
27893178	530	535	RGNTs	T038	UMLS:C2363902
27893178	573	589	genetic analyses	T058	UMLS:C0796344
27893178	593	598	glial	T017	UMLS:C0027836
27893178	603	613	neurocytic	T017	UMLS:C0027882
27893178	614	624	components	T017	UMLS:C0243092
27893178	633	638	RGNTs	T038	UMLS:C2363902
27893178	643	649	tissue	T017	UMLS:C0475358
27893178	650	665	microdissection	T058	UMLS:C0598304
27893178	671	689	missense mutations	T038	UMLS:C0599155
27893178	693	698	FGFR1	T017	UMLS:C0919509
27893178	707	717	components	T017	UMLS:C0243092
27893178	740	748	mutation	T038	UMLS:C0026882
27893178	752	758	PIK3CA	T017	UMLS:C1335212
27893178	767	777	components	T017	UMLS:C0243092
27893178	796	804	detected	T033	UMLS:C0442726
27893178	830	845	PIK3CA mutation	T038	UMLS:C3272694
27893178	862	867	FGFR1	T017	UMLS:C0919509
27893178	868	876	mutation	T038	UMLS:C0026882
27893178	881	889	detected	T033	UMLS:C0442726
27893178	902	907	glial	T017	UMLS:C0027836
27893178	908	917	component	T017	UMLS:C0243092
27893178	933	955	loss of chromosome 13q	T038	UMLS:C2930913
27893178	968	978	neurocytic	T017	UMLS:C0027882
27893178	979	988	component	T017	UMLS:C0243092
27893178	1050	1055	RGNTs	T038	UMLS:C2363902
27893178	1067	1073	tumors	T038	UMLS:C0027651
27893178	1088	1114	divergent differentiations	T033	UMLS:C3641779
27893178	1140	1145	clone	T017	UMLS:C0009013
27893178	1228	1233	RGNTs	T038	UMLS:C2363902
27893178	1238	1260	pilocytic astrocytomas	T038	UMLS:C0334583
27893178	1262	1265	PAs	T038	UMLS:C0334583
27893178	1286	1291	tumor	T038	UMLS:C0027651
27893178	1314	1321	confirm	T033	UMLS:C0750484
27893178	1353	1358	RGNTs	T038	UMLS:C2363902
27893178	1387	1389	PA	T038	UMLS:C0334583